Adapted CAR-T Therapy Shows Promise in Myasthenia Gravis
The first study to use an RNA-based chimeric antigen receptor T-cell (rCAR-T)…
Browsing Tag
Myasthenia
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for…
First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG patients treated with VYVGART were responders (n=44/65) on the Myasthenia Gravis…
FDA Greenlights New Myasthenia Gravis Drug
The FDA approved rozanolixizumab-noli (Rystiggo), a neonatal Fc receptor…
Muscular Dystrophy Association Celebrates FDA Approval of UCB’s RYSTIGGO for the…
New York, June 27, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of RYSTIGGO (rozanolixizumab-noli) for…
Muscular Dystrophy Association Celebrates FDA Approval of argenx’s Vyvgart Hytrulo…
New York, June 20, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of subcutaneous (SC) Vyvgart Hytrulo…
Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5%…
<!-- Name:DistributionId Value:8839512 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Myasthenia Gravis Tied to Elevated Risk for Severe COVID
People with myasthenia gravis were at higher risk for severe cases of COVID-19, including…
Gene mutation discovered that causes language impairment, ADHD and myasthenia
Two studies have revealed that certain disorders of the CAPRIN1 gene have significant consequences for people. First, the research team showed that insufficient production of the protein…
Rheumatoid arthritis drug effective against myasthenia
Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes…
Zai Lab Announces Acceptance by China’s NMPA of the BLA for Efgartigimod for Patients…
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., July 13, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global…